Page results
-
This provides information about a treatment for uterine fibroids known as ‘transcervical ultrasound-guided radiofrequency ablation’. You may also hear it called by the Manufacturer’s name ‘Sonata®’ for short.
-
A new trial led by UCLH and UCL is looking at whether music therapy can help patients recover from severe brain injury.
-
This page provides information about the thermoregulatory sweat test (TST).
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
-
If you need an assessment by a midwife or doctor that is outside of your routine antenatal appointments you will be invited to attend the Maternal and Fetal Assessment Unit (MFAU).
-
Our new report shows the difference charitable funds can make to patients, staff and research at UCLH
-
Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.
-
Miss Nathalie Zaidman is a consultant spinal neurosurgeon specialising in complex spinal surgery.
-
This page explains what FACETS is and how it can help you.
-
To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.
File results
-
FOI/2024/0518 - Post partum balloons buying/ usage numbers
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0528 - Open MRIs referrals for patient size/ spend on specialist bariatric equipment 2017-2024
-
FOI/2024/0529 - Medical Associate Professionals (MAPs) at Trust
-
FOI/2024/0530 - Radiology/ imaging examinations/ patient access to radiology images
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer